163P Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: Findings from the CAVE-lung trial
- Resource Type
- Source
- Annals of Oncology. 33:S107-S108
- Subject
Oncology Hematology - Language
- ISSN
- 0923-7534